2025. Serum Markers Predicting Early Non-Responsiveness to Infliximab in Rheumatoid Arthritis: Tumor Necrosis Factor (TNF)-Alpha, TNFRII, and Interleukin (IL)-17 As Potential Indicators. Iraqi Journal of Medical Sciences. 23, 1 (Jun. 2025). DOI:https://doi.org/10.22578/qchesh02.